TY  - JOUR
AU  - Pérez-Ramírez, Cristina
AU  - Cañadas-Garre, Marisa
AU  - Molina, Miguel Ángel
AU  - Robles, Ana I
AU  - Faus-Dáder, María José
AU  - Calleja-Hernández, Miguel Ángel
PY  - 2016
DO  - 10.1016/j.mrrev.2016.11.003
UR  - http://hdl.handle.net/10668/11005
T2  - Mutation research. Reviews in mutation research
AB  - Although platinum-based chemotherapy remains the standard treatment for advanced NSCLC patients, clinical outcomes are poor and most patients develop high-grade toxicities. Genetic factors, such as single nucleotide polymorphisms (SNPs) involved in...
LA  - en
KW  - Non-small cell lung cancer
KW  - Platinum based chemotherapy
KW  - Polymorphisms
KW  - Response
KW  - Survival
KW  - Toxicity
KW  - Antineoplastic Agents
KW  - Carcinoma, Non-Small-Cell Lung
KW  - DNA Repair
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Lung Neoplasms
KW  - Organoplatinum Compounds
KW  - Prognosis
TI  - Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer.
TY  - research article
VL  - 771
ER  -